Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity

Microbial drug resistance (Larchmont, N.Y.) (2021) - Comment
doi: 10.1089/mdr.2020.0232 issn: 1076-6294 issn: 1931-8448 pubmed: 33729874

Guillaume Hache, Jean Marc Rolain, Philippe Gautret, Jean-Claude Deharo, Philippe Brouqui, Didier Raoult, Stéphane Honoré